title: Desipramine and cutaneous reactions in pediatric outpatients.
abstract: The association of adverse cutaneous effects with administration of the tricyclic antidepressant drug desipramine was systematically reviewed in a clinic population of 205 child psychiatry outpatients over a 3-year period. Transient maculopapular rashes developed in 12 children and adolescents treated with desipramine. The rashes had a benign course, disappearing completely in 2 to 7 days, and were not associated with clinical or chemical hepatitis or any other physical symptoms.
authors.affiliation: Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
authors.forename: J
authors.initials: J
authors.lastname: Biederman
authors.forename: E
authors.initials: E
authors.lastname: Gonzalez
authors.forename: B
authors.initials: B
authors.lastname: Bronstein
authors.forename: H
authors.initials: H
authors.lastname: De Monaco
authors.forename: V
authors.initials: V
authors.lastname: Wright
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000553:Ambulatory Care; D001008:Anxiety Disorders / Q000188:drug therapy; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy; D003891:Desipramine / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008404:Massachusetts; D012189:Retrospective Studies
chemical_list: D003891:Desipramine